MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January 23, 2026. The company’s Board of Directors has appointed Greg Hunter, currently chief financial officer, to serve as interim chief executive officer while it evaluates long‑term leadership options. Hunter will continue to serve simultaneously as CFO during the interim period.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Curaleaf announces net revenue for Q4 2025 expected to be at least $330 million, an increase of approximately 4 per cent sequentially and 1 per cent compared to Q4 2024
2 | MariMed launches hemp-derived THC products under its Vibations brand in Rhode Island
3 | Cannabix marijuana breath test featured on the cover of AlcoPro’s 2026 product catalogue
4 | Simply Solventless acquires Brand Uncommon Cannabis Co.
Top Cannabis Stocks Jan. 16 to Jan. 22, 2026
1. T.CURA | 8,276 views | Curaleaf Holdings Inc.
2. T.TLRY | 7,521 views | Tilray Brands Inc.
3. T.LABS | 3,476 views | Medipharm Labs Corp.
4. C.TGIF | 696 views | 1933 Industries Inc.
5. C.BLO | 505 views | Cannabix Technologies Inc.
6. T.OGI | 405 views | Organigram Global Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
